Search

everythinglearnresearchcommunity

for

Search:↓

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Compound 15a was effective in inhibiting 5α-reductase.

Clascoterone cream could be used for other skin conditions affected by hormones.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Anabolic steroids and inflammation can disrupt androgen metabolism, potentially causing health issues.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Clascoterone is safe for the heart, even at high doses.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Nandrolone phenylpropionate injections thickened the skin and enlarged oil glands in female hairless hamsters.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

RU 58841 may treat acne, hair loss, and excessive hair growth.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.